A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
CRISPR Therapeutics
Alliance for Clinical Trials in Oncology
Symphogen A/S
Massachusetts General Hospital
Quadriga Biosciences, Inc.
Incyte Corporation
Shionogi Inc.
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
Stanford University
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)